2025-525042-22-00RecruitingPhase 1
A Study to Evaluate the Safety and Activity of an Inhaled Investigational Drug (RO7616605) in Healthy Volunteers and Participants With COPD
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Genentech Inc.
- Enrollment
- 104
- Locations
- 2
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (65+ Years, 18-64 Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
US Program Manager Product Development Regulatory
Scientific
Genentech Inc.
Study Sites (2)
Loading locations...
Similar Trials
Recruiting
Phase 1
A Study to Evaluate the Safety and Tolerability of ARV-806 in Adults with Advanced Cancer that has the KRAS G12D MutationKRAS G12D Mutated Advanced Solid Tumors2025-521062-10-00Arvinas Operations Inc.51
Completed
Phase 1
A Study to Evaluate the Safety and Tolerability of JNJ-77730614 When Given as Single and Multiple Doses to Healthy Participants to Assess How Long JNJ 77730614 Stays in the Body (Pharmacokinetics) and How the Body Responds to it (Pharmacodynamics)Healthy Volunteers2023-505684-36-00Janssen - Cilag International92
Recruiting
Phase 1
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).liver cirrhosis2024-515074-26-00AgomAb Therapeutics64
Recruiting
Phase 1
A Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy ParticipantsEpilepsy, amotrophic lateral sclerosis, neuropathy2025-524310-28-00Quralis Corp.48
Recruiting
Phase 1
A study on the safety, tolerability, and effectiveness of the new drug LAD106 in healthy volunteers.Inflammatory diseases2025-523328-31-00Almirall S.A.93